EuroMRD Ph+ALL 2025
Resources
More information on the EuroMRD website and the EuroMRD member login area (including a Q&A on the EuroMRD EQA program).
Publications
Pfeifer et al., Standardisation and consensus guidelines for minimal residual disease assessment in Philadelphia-positive acute lymphoblastic leukemia (Ph + ALL) by real-time quantitative reverse transcriptase PCR of e1a2 BCR-ABL1. Leukemia 2019;33:1910-1922.
www.nature.com
Updated guidelines 2024: Van der Velden et al., Leukemia 2024;38:1315-22: Analysis of measurable residual disease by IG/TR gene rearrangements: quality assurance and updated EuroMRD guidelines
www.nature.com